Christophe Bourdon

Christophe Bourdon

Direttore/Membro del Consiglio presso SWEDISH ORPHAN BIOVITRUM AB
56 anni
Health Technology
Consumer Services
Health Services

Profilo

Christophe Bourdon is Chief Executive Officer at LEO Pharma A since 2022.
Mr. Bourdon is Director at Swedish Orphan Biovitrum AB since 2023.
Former roles include Chief Executive Officer at Strategic Partners A from 2021 to 2022, Senior Vice President & General Manager-US Oncology at Amgen, Inc. from 2020 to 2021, and Senior VP-Europe, Middle East, Africa & Canada at Alexion Pharmaceuticals, Inc. from 2015 to 2017.
Education includes an MBA from International Institute for Management Development and an undergraduate degree from Institut Supérieur de Gestion.

Posizioni attive di Christophe Bourdon

SocietàPosizioneInizio
SWEDISH ORPHAN BIOVITRUM AB Direttore/Membro del Consiglio 01/01/2023
Amministratore Delegato 01/01/2022

Precedenti posizioni note di Christophe Bourdon

SocietàPosizioneFine
STRATEGIC PARTNERS A/S Amministratore Delegato 01/04/2022
AMGEN INC. Corporate Officer/Principal 01/03/2021
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2017
Vedi nel dettaglio l'esperienza di Christophe Bourdon

Formazione di Christophe Bourdon

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

61

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

Health Technology

Consumer Services

  1. Mercati
  2. Insiders
  3. Christophe Bourdon